Neutra Life Sciences Expands Clinical Research Footprint Through Strategic Partnerships

Neutra Life Sciences, a subsidiary of Neutra Corp (OTC: NTRR), has announced the formation of new joint venture partnerships with Epic Foot & Ankle Centers, Aspire Hospital Cancer Centers, and Radiant Dermatology & Aesthetics Clinic. These collaborations represent a significant expansion of the company's multi-specialty platform, enabling it to address the increasing demand for diverse clinical research solutions across podiatry, radiation oncology, and dermatology.

The strategic partnerships allow Neutra Life Sciences to extend its services to a broader patient demographic and provide comprehensive support to Contract Research Organizations (CROs) and Sponsors in various therapeutic areas. Sydney Jim, President and CEO of Neutra Corp, highlighted the strategic importance of these partnerships, noting their role in expanding service offerings and driving innovation in patient care and research.

In a strategic pivot, Neutra Corp has also announced the winding down of its subsidiary, VIVIS Corporation, which was focused on hemp-based cannabis. This move reflects the company's decision to concentrate its resources and leadership on the life sciences sector, particularly in areas with stable regulatory environments and significant long-term growth potential.

Neutra Life Sciences' recent initiatives underscore its commitment to advancing clinical research and improving health outcomes through innovative collaborations. For further details on Neutra Corp's endeavors in the life sciences sector, visit https://www.neutrainc.com.